February 22, 2011

Sales at Medco Health Solutions increased to $16.9 billion during fourth quarter 2010 and to $66 billion for the fiscal year as a whole, representing respective 11.1% and 10.3% increases over the same periods the year before, the pharmacy benefit manager said Tuesday.

February 18, 2011

ROCHESTER, N.Y. — Blood-pressure kiosks have become a ubiquitous site in retail pharmacies across the country, but like pharmacy automation and technology as a whole, they’re continuing to advance and offer new features.

February 18, 2011

In November 2010, The Drug Store News Group/Specialty Pharmacy magazine hosted in New York an exclusive executive round-table discussion of leading specialty pharmacy providers. Guest moderator David Galardi of Apogenics and the panel examine why more therapeutic classes are migrating to a specialty-preferred model, working with Medicaid, genetic testing and REMS.

February 18, 2011

The Food and Drug Administration has approved a treatment for a rare bleeding disorder.

February 18, 2011

Technology is not only bringing more benefits to patients in the pharmacy, but it’s also offering them a host of products so they can be more involved in their health care. This was a theme at the National Council for Prescription Drug Programs’ educational summit, “Leveraging New Technologies: Impact on the Patient and the Healthcare Industry,” on Feb. 8 in Las Vegas.


February 17, 2011

The Obama administration’s proposed budget for 2012 contains an item that could change the game for biosimilars, according to published reports.

February 17, 2011

Savient Pharmaceuticals announced changes to its management team as it gears up for the commercial launch of its chronic gout treatment.

February 17, 2011

Diplomat Specialty Pharmacy has hired a new CFO, the company said.

February 16, 2011

Amicus Therapeutics received good results from its mid-stage trial of a drug for a rare, genetic disorder, the drug maker said Wednesday.

February 16, 2011

French drug maker Sanofi-Aventis will acquire U.S. biotech giant Genzyme for $20.1 billion, under an agreement the two companies announced Wednesday.

February 14, 2011

The Food and Drug Administration has accepted for review an application for a pain medication designed to thwart drug abusers.

February 14, 2011

Gilead Sciences has refiled an approval application with the Food and Drug Administration for an HIV drug, the drug maker said.

February 14, 2011

Following the exit of its oncology unit leader, drug maker Eli Lilly announced two executive changes.

February 11, 2011

Irish biotech company Elan and German drug maker Boehringer Ingelheim will collaborate to develop and manufacture antibody-based medicines.

February 11, 2011

The Food and Drug Administration announced Friday the approval of Waltham, Mass.-based Thermo Fisher’s QMS Everolimus Immunoassay, a test that monitors the blood for levels of Novartis’ drug Zortress (everolimus).

February 11, 2011

The Food and Drug Administration has approved a drug for preventing preterm births.

February 11, 2011

The Food and Drug Administration has approved a painkiller delivered through a skin patch made by Mallinckrodt, the generic drug maker said Friday.

February 9, 2011

Women with ovarian cancer who received a drug made by Genentech lived longer without their disease becoming worse, according to a late-stage clinical trial.

February 9, 2011

Sandoz is developing as many as 10 new follow-on biologics, according to published reports.

February 8, 2011

The Food and Drug Administration has given expedited review to a drug for preventing hemodialysis failure in patients with end-stage kidney disease.

February 7, 2011

The Food and Drug Administration has approved a generic cancer drug from Hospira.

February 4, 2011

AmerisourceBergen on Friday reported revenue of $19.9 billion, up 2.9%, for the first quarter ended Dec. 31.

February 4, 2011

A specialty pharmacy focused on infertility is sponsoring a giveaway campaign to attract patients to its Web-based forum.

February 3, 2011

A bill that would make the biggest changes to patent laws in more than half a century has drawn mixed responses from the drug industry.